<DOC>
	<DOCNO>NCT01591512</DOCNO>
	<brief_summary>The purpose study collect sample evaluate ProGRP NSE assay independently aids monitoring course disease therapy subject diagnose SCLC .</brief_summary>
	<brief_title>A Prospective Longitudinal Collection Subjects Diagnosed With Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Small Cell Lung Carcinoma</mesh_term>
	<criteria>Age â‰¥ 18 Confirmed diagnosis SCLC mixed SCLC/nonSCLC per histopathology result Scheduled undergo first , second thirdline treatment SCLC , include chemotherapy , chemotherapy + radiation therapy , combine concurrent chemoradiotherapy . Able understand willing provide Informed Consent No diagnosis SCLC Not schedule undergo treatment diagnosis SCLC Unable provide Informed Consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Small Cell Lung Cancer</keyword>
	<keyword>SCLC</keyword>
	<keyword>Lung Cancer</keyword>
	<keyword>Subjects diagnose SCLC undergo treatment</keyword>
</DOC>